John A. Roberts - May 24, 2021 Form 4/A - Amendment Insider Report for Vyant Bio, Inc. (VYNT)

Role
Chief Executive Officer
Signature
/s/ Andrew LaFrence, attorney-in-fact
Stock symbol
VYNT
Transactions as of
May 24, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
8/25/2021, 04:59 PM
Date Of Original Report
May 27, 2021
Next filing
Aug 25, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VYNT Common Stock, $0.0001 par value 24.4K May 24, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 27, 2021, the reporting person filed a Form 4, which inadvertently reported the shares owned on a pre-split basis. This amended Form 4 is being filed to reflect the shares owned following the 1-for-30 reverse stock split effected October 24, 2019.